Combretastatin A4及其类似物在大肠肿瘤治疗中的研究进展
出处
《滨州医学院学报》
2010年第1期57-59,共3页
Journal of Binzhou Medical University
参考文献18
-
1Siemann DW, Chaplin DJ, Horsman MR. Vascular-targeting therapies for treatment of malignant disease[ R]. Cancer,2004,100(12) : 2491-2499.
-
2Cao Y. Antiangiogenic cancer therapy [ J ]. Semin Cancer Biol. 2004,14 ( 2 ) : 139-145.
-
3Kinuya S, Yokoyama K, Koshida K,et al. Improved survival of mice bearing liver metastases of colon cancer ceils treated with a combination of radioimmunotherapy and antiangiogenic therapy [ J ]. Eur J Nucl Med Mol Imaging,2004,31 ( 7 ) :981-985.
-
4Gaya AM, Rustin GJ. Vascular disrupting agents : a new class of drug in cancer therapy [ R ]. Clin Oncol ( R Coil Radiol) , 2005,17 ( 4 ) : 277 -290.
-
5Midulla M, Verma R, Pignatelli M ,et al. Source of oncofetal ED-B- containing fibronectin : implications of production by both tumor and endothelial cells [ J ]. Cancer Res,2000,60 ( 1 ) : 164-169.
-
6West CM, Price P. Combretastatin A4 phosphate Anticancer Drugs [ R]. Clin Cancer Res,2004,15(3) :179-187.
-
7Thorpe PE. Vascular targeting agents as cancer therapeutics [ R ]. C|in Cancer Res ,2004,15 (6) :415-427.
-
8Pettit GR, Singh SB, Hamel E, et al. Isolation and structure of the strong cell growth and tubulin inhibitor combretastatin A4 [ J]. Experientia, 1989,45 (2) :209-211.
-
9Lin CM, Ho HH,Pettit GR,et al. A ntimitotic natural products combretastatin A-4 and eombretastatin A-2:studies on the mechanism of their inhibition of the binding of eolchieine to tubulin [ J ]. Biochemistry,1989,28(17):6984-6991.
-
10Gurjar MK, Wakharkar RD, Singh AT,et al. Synthesis and evaluation of 4/5-hydroxy-2,3-diaryl ( substituted ) -cyclopent-2-en-1 -ones as cis-restricted analogues of combretastatin A-4 as novel anticancer agents [ J ]. J Med Chem,2007,50 ( 8 ) : 1744-1753.
-
1王小桦,张静渊,曲军卫,王金华.宫颈NK/T细胞淋巴瘤临床病理分析[J].实用临床医药杂志,2013,17(24):164-165. 被引量：2
-
2杨武双,刘金凤,杨德林,岳武.COX-2选择性抑制剂Celecoxib治疗胶质瘤的体内实验研究1231[J].肿瘤防治研究,2005,32(2):67-69.
-
3冯腾,耿美玉,李静.小分子肿瘤血管破坏剂研究进展[J].中国新药杂志,2010,19(24):2285-2289. 被引量：1
-
4万军.结外鼻型NK/T细胞淋巴瘤的研究进展[J].中国医药指南,2013,11(10):60-62. 被引量：2
-
5贾万钧,郭艳.鼻NK/T淋巴瘤临床病理分析及免疫组化研究[J].浙江临床医学,2007,9(9):1267-1268.
-
6潘颂华,孙兮文,叶春涛,郑晓春,嵇鸣,陈素珍.前列腺癌局部侵犯的MRI评价[J].上海医学影像,2003,12(3):183-185.
-
7赵静,易成.鼻和鼻型NK/T细胞淋巴瘤的治疗进展[J].中国肿瘤临床,2006,33(14):836-839. 被引量：14
-
8刘勇.淋巴结梗死:潜在恶性病变、肿瘤增殖分数和血管损伤的作用[J].临床与实验病理学杂志,2013,29(8):880-880.
-
9何佳骏,何珩,熊霞.结外NK/T细胞淋巴瘤2例并文献复习[J].中国皮肤性病学杂志,2016,30(8):817-819. 被引量：1
-
10蒋蕾,霍介格.考布他汀A4磷酸酯(CA4P)抗肿瘤作用研究进展[J].现代肿瘤医学,2012,20(3):643-645. 被引量：4
